Les tumeurs myofibroblastiques inflammatoires : association fortuite ou complication peu connue du post-partum ?

Chelbi, Emna; Chadli-Debbiche, Aschraf; Ferchiou, M.; Ajmi, Chiraz; Kourda, N; Labbéne, N; Khayat, Omar Wishyar Al; Zermani, R; Chérif, Rim; Ayed, M. Ben

doi:10.1016/j.gyobfe.2010.08.020

Cited by 3 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indeed, the literature review found, to our knowledge, only four cases of extra uterine IMT in a postpartum context: a mesovarian site IMT on day 1 postpartum, a liver IMT revealed on day 4 postpartum, a case of pulmonary IMT discovered 5 months postpartum, and a case of breast IMT also in a postpartum context. Three other cases have been described in pregnant women [11], and 28 cases of placental associated IMT with apparently benign course [12].With the largest case study on the matter so far (9 cases), Makhdoum and al raise an interesting question about placental and uterine IMT compelling they may be a subtype within the group of uterine IMT with specific molecular characteristics which may be related to the hormonal milieu [12].These studies have corroborated our hypothesis stating that hormonal changes during and after pregnancy may be one of the underlying causes of IMT in the per and postpartumperiod.…”

Section: Discussion:-mentioning

confidence: 98%

Inflammatory Myofibroblastic Tumors in the Peculiar Context of the Postpartum Case Report

C.¹,

Ibnoulkhatib²,

A.³

et al. 2021

IJAR

View full text Add to dashboard Cite

The debate persists about the inflammatory or tumoral, benign or malignant nature of the Inflammatory myofibroblastic tumors (TMI). Radioclinically, they can mimic a malignant neoplasm, although they are classified as intermediate by the World Health Organization (WHO). The diagnosis is almost always made by pathological examination. The treatment is poorly codified but the management is usually surgical. The removal of these tumors is a challenge when the mass is developed at the expense of or in the vicinity of noble organs. Several therapies have been tested to overcome the limitations of surgery, the results are variable. These tumors rarely affect the digestive tract. We propose the study of a case of myofibroblastic tumor developed at the expense of the omentum, five months after a cesarean section, in order to try to determine if it is a rare complication of the postpartum or a fortuitous combination.

show abstract

Section: Discussion:-mentioning

confidence: 98%

Inflammatory Myofibroblastic Tumors in the Peculiar Context of the Postpartum Case Report

C.¹,

Ibnoulkhatib²,

A.³

et al. 2021

IJAR

View full text Add to dashboard Cite

show abstract

Tumor miofibroblástico de origen ovárico: comportamiento agresivo y fatal

Prieto

Forero

Acosta

et al. 2016

Revista Colombiana de Cancerología

View full text Add to dashboard Cite

Inflammatory Myofibroblastic Tumor of the Placenta

Banet

Ning

Montgomery

2015

International Journal of Gynecological Pathology

View full text Add to dashboard Cite

Inflammatory myofibroblastic tumor has been described in a wide variety of anatomic sites, although in the gynecologic tract, it has mostly been documented in the uterus, and has never been described in the placenta. Two patients presented with well-circumscribed placental masses that showed classic histologic features of inflammatory myofibroblastic tumor including a proliferation of myofibroblastic cells, a mixed inflammatory infiltrate, and a myxoid background. One case was positive by immunohistochemistry for anaplastic lymphoma kinase (ALK-1), whereas the other was negative by immunohistochemistry and fluorescent in situ hybridization. Inflammatory myofibroblastic tumors should be differentiated from other more aggressive uterine tumors that may involve the placenta by direct extension/metastasis because they can be managed conservatively, and in these 2 cases, did not seem to affect the course of the patient's pregnancies.

show abstract

Les tumeurs myofibroblastiques inflammatoires : association fortuite ou complication peu connue du post-partum ?

Cited by 3 publications

References 8 publications

Inflammatory Myofibroblastic Tumors in the Peculiar Context of the Postpartum Case Report

Inflammatory Myofibroblastic Tumors in the Peculiar Context of the Postpartum Case Report

Tumor miofibroblástico de origen ovárico: comportamiento agresivo y fatal

Inflammatory Myofibroblastic Tumor of the Placenta

Contact Info

Product

Resources

About